We would like to share with our clients and colleagues this important letter regarding the priority given to clinical trials in Israel by the MoH.
We are always here to assist you in your clinical trial. Feel free to reach out!
GET A QUOTE
Blog
12/06/2025
Risk Management and Vendor Partnerships in Clinical Trials Logistics: Building Resilient Supply Chains
In clinical trials, logistics are the invisible backbone. From investigational medicinal products (IMPs) and ancillary supplies to temperature-controlled storage and timely distribution, each element must function with precision. But what happens when a link in the chain breaks? Supply chain disruptions—caused by global events, vendor failures, regulatory hurdles, or logistical delays—can jeopardize timelines, budgets, and, […]
Blog
08/06/2025
From Contract to Collaboration: Navigating Vendor Management in Clinical Trials
We’re pleased to invite you to a short seminar Date: Wednesday, July 23rd, 2025 Time: 08:30–13:00 Location: Alon Hall, IMP Facility (SLE), Hate’ena 1 st., Modiin Region Industrial Park Waze: סלא טבע שוהם Join us for a focused and insightful seminar exploring the evolving landscape of vendor management in clinical trials — from oversight to strategic collaboration, from […]
Blog
27/02/2025
Navigating 29C Importation in Israel
What is 29C Importation? Regulation 29C governs the importation of non-registered medicinal products into Israel under specific conditions. This regulation allows hospitals, healthcare providers, and sponsors to access treatments that are not locally registered but are essential for patient care. These imports often support clinical trials, compassionate use programs, or off-label treatments when no registered […]